Skip to main content
Caplight Logo









Synteny

Synteny

Private
LondonHealthcare & Life Scienceshttps://synteny.ai/

Last Round

Grant

Mar 1, 2024

Total Funding Raised

$3.17M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Synteny is a biotechnology company that develops an AI-driven platform for decoding molecular recognition to design precision TCR bispecific therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Infrastructure

Keywords

drug discoveryprotein therapeuticsT-cell receptorTCRgenerative AIlab-in-the-loopAI drug discoveryprecision medicinesynthetic biologyprotein designbiotech platformin silico drug designcomputational biologybispecific antibodiesfoundational AIAI-native biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synteny Comparables

Compare Synteny with similar companies based on industry and business-model similarity.

Synteny comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
3T Biosciences
84%
Cradle
78%
Nabla Bio
78%

Synteny Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 1, 2024
Series AOct 1, 2023

Synteny Investors

Notable investors and investment history

Synteny investors
InvestorRounds
Obvious VenturesSeries A
Amplifyher VenturesSeries A
Innovate UKGrant
Black Opal VenturesSeries A
In-Q-TelSeries A
Springboard Health AngelsSeries A
MMC VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 18, 2026

    Grew 16% QoQ, from 19 to 22 employees.

  • Jun 3, 2026

    Grew 31% QoQ, from 16 to 21 employees.

Synteny Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Synteny Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synteny's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range22
Year Founded2021
Last FundingMar 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?